This new research group could shed light on how immune cells can better fight cancers or step back in autoimmune disease, and could open the door to new cancer therapies or treatments for autoimmune diseases. The work is part of a larger collaboration led by Professor Mark Ginsberg, M.D., of the University of California, San Diego, School of Medicine.
Ginsberg commented: “A major strength of this program are the remarkable synergies amongst established senior investigators such as Dr. Ley with a leading academic hematologist, Dr. Sanford Shattil, and a very productive early career Vascular Biologist, Dr. Miguel Alejandro Lopez-Ramirez, and myself at UCSD. This NIH award enables these interactions which are facilitated by analyses of hemostasis, thrombosis, and inflammation in genetically-modified mice in a Scientific Core led by Prof. Wolfgang Bergmeier (University of North Carolina), an exceptional mid-career scientist.”
The new project is NHLBI grant number 1P01HL151433.